001     16901
005     20240709081614.0
024 7 _ |2 pmid
|a pmid:20347551
024 7 _ |2 DOI
|a 10.1007/s10971-010-2321-7
024 7 _ |2 WOS
|a WOS:000285974700008
037 _ _ |a PreJuSER-16901
041 _ _ |a eng
082 _ _ |a 600
084 _ _ |2 WoS
|a Materials Science, Ceramics
100 1 _ |a Dippel, A.-C.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB68378
245 _ _ |a PbTiO3 nanoparticle precursors for chemical solution deposited electroceramic thin films
260 _ _ |a Dordrecht [u.a.]
|b Springer Science + Business Media B.V
|c 2011
300 _ _ |a 36 - 42
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Journal of Sol-Gel Science and Technology
|x 0928-0707
|0 14361
|y 1
|v 57
500 _ _ |3 POF3_Assignment on 2016-02-29
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a The Vascular Registry (VR) on carotid procedures collects long-term outcomes on carotid artery stenting (CAS) and carotid endarterectomy (CEA) patients. The purpose of this report is to describe in-hospital and 30-day CAS outcomes in patients with atherosclerotic carotid artery disease (CAD; atherosclerosis [ATH]) compared to recurrent carotid stenosis (RES) and radiation-induced stenosis (RAD).The VR collects provider-reported data on CAS using a Web-based data management system. For this report, data were analyzed at the preprocedure, procedure, predischarge, and 30-day intervals.As of November 20, 2008, there were 4017 patients with CAS with discharge data, of which 72% were due to ATH. A total of 2321 patients were available for 30-day outcomes analysis (1623 ATH, 529 restenosis, 119 radiation, 17 dissection, 3 trauma, and 30 other). Baseline demographics showed that ATH occurred in older patients (72-years-old), had the greatest history of coronary artery disease (CAD; 62%), myocardial infarction (MI; 24%), valvular heart disease (8%), arrhythmia (16%), congestive heart failure (CHF; 16%), diabetes mellitus (DM; 35%), and chronic obstructive pulmonary disease (COPD; 20%). RES had a higher degree of baseline stenosis (87.0 vs 85.8 ATH; P = .010), were less likely to be symptomatic (35.5% vs 46.3% ATH; P < .001), but had a greater history of hypertension, peripheral vascular disease (PVD), and smoking. RAD was seen in younger patients (66.6 vs 71.7 ATH; P < .001), were more likely to be male (78.2% vs 60.9% ATH; P < .001), and had less comorbidities overall, with the exception of amaurosis fugax, smoking, and cancer. The only statistically significant difference in perioperative rates was in transient ischemic attack (TIA; 2.7% ATH vs 0.9% RES; P = .02). There were no statistically significant differences in in-hospital death/stroke/MI (ATH 5.4%, RES 3.8%, RAD 4.2%) or at 30 days (ATH 7.1%, RES 5.1%, RAD 5.0%). Even after adjusting for age, gender, symptomatology, CHF, and renal failure, the only statistically significant difference at 30 days was amaurosis fugax between ATH and RAD (odds ratio [OR] 0.13; P = .01).Although patients with ATH have statistically significant comorbidities, they did not have statistically significant increased rates of death/stroke/MI during hospitalization or within 30 days after discharge when compared to RES or RAD. The CAS event rates for ATH vs RES and RAD are similar, despite prior published reports. Symptomatic ATH have statistically significant higher rates of death/stroke/MI compared to asymptomatic cohort. Finally, consistent and accurate entry of long-term data beyond initial hospitalization is essential to fully assess CAS outcomes since a significant number of adverse events occur in the interval from hospital discharge to 30 days.
536 _ _ |a Atmosphäre und Klima
|c P23
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK491
|x 0
536 _ _ |a Grundlagen für zukünftige Informationstechnologien
|c P42
|0 G:(DE-Juel1)FUEK412
|x 1
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Aged
650 _ 2 |2 MeSH
|a Aged, 80 and over
650 _ 2 |2 MeSH
|a Analysis of Variance
650 _ 2 |2 MeSH
|a Angioplasty: instrumentation
650 _ 2 |2 MeSH
|a Angioplasty: methods
650 _ 2 |2 MeSH
|a Angioplasty: mortality
650 _ 2 |2 MeSH
|a Atherosclerosis: pathology
650 _ 2 |2 MeSH
|a Atherosclerosis: surgery
650 _ 2 |2 MeSH
|a Atherosclerosis: ultrasonography
650 _ 2 |2 MeSH
|a Carotid Stenosis: mortality
650 _ 2 |2 MeSH
|a Carotid Stenosis: pathology
650 _ 2 |2 MeSH
|a Carotid Stenosis: surgery
650 _ 2 |2 MeSH
|a Carotid Stenosis: ultrasonography
650 _ 2 |2 MeSH
|a Cohort Studies
650 _ 2 |2 MeSH
|a Endarterectomy, Carotid: adverse effects
650 _ 2 |2 MeSH
|a Endarterectomy, Carotid: methods
650 _ 2 |2 MeSH
|a Female
650 _ 2 |2 MeSH
|a Hospital Mortality: trends
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Male
650 _ 2 |2 MeSH
|a Middle Aged
650 _ 2 |2 MeSH
|a Odds Ratio
650 _ 2 |2 MeSH
|a Postoperative Complications: epidemiology
650 _ 2 |2 MeSH
|a Postoperative Complications: physiopathology
650 _ 2 |2 MeSH
|a Probability
650 _ 2 |2 MeSH
|a Prosthesis Failure
650 _ 2 |2 MeSH
|a Registries
650 _ 2 |2 MeSH
|a Risk Assessment
650 _ 2 |2 MeSH
|a Severity of Illness Index
650 _ 2 |2 MeSH
|a Societies, Medical
650 _ 2 |2 MeSH
|a Stents
650 _ 2 |2 MeSH
|a Survival Analysis
650 _ 2 |2 MeSH
|a Ultrasonography, Doppler, Duplex
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a Lead titanate
653 2 0 |2 Author
|a Nanoparticles
653 2 0 |2 Author
|a Chemical solution deposition
653 2 0 |2 Author
|a Thin films
653 2 0 |2 Author
|a Ferroelectrics
653 2 0 |2 Author
|a Reverse micelles
700 1 _ |a Schneller, T.
|b 1
|u FZJ
|0 P:(DE-Juel1)VDB3028
700 1 _ |a Dornseiffer, J.
|b 2
|u FZJ
|0 P:(DE-Juel1)129189
700 1 _ |a Waser, R.
|b 3
|u FZJ
|0 P:(DE-Juel1)131022
773 _ _ |a 10.1007/s10971-010-2321-7
|g Vol. 57, p. 36 - 42
|p 36 - 42
|q 57<36 - 42
|0 PERI:(DE-600)1472726-2
|t Journal of sol gel science and technology
|v 57
|y 2011
|x 0928-0707
856 7 _ |u http://dx.doi.org/10.1007/s10971-010-2321-7
909 C O |o oai:juser.fz-juelich.de:16901
|p VDB
|p VDB:Earth_Environment
913 1 _ |k P23
|v Atmosphäre und Klima
|l Atmosphäre und Klima
|b Erde und Umwelt
|z vormals P22
|0 G:(DE-Juel1)FUEK491
|x 0
913 1 _ |k P42
|v Grundlagen für zukünftige Informationstechnologien
|l Grundlagen für zukünftige Informationstechnologien (FIT)
|b Schlüsseltechnologien
|0 G:(DE-Juel1)FUEK412
|x 1
913 2 _ |a DE-HGF
|b Marine, Küsten- und Polare Systeme
|l Atmosphäre und Klima
|1 G:(DE-HGF)POF3-240
|0 G:(DE-HGF)POF3-249H
|2 G:(DE-HGF)POF3-200
|v Addenda
|x 0
913 2 _ |a DE-HGF
|b Key Technologies
|l Future Information Technology - Fundamentals, Novel Concepts and Energy Efficiency (FIT)
|1 G:(DE-HGF)POF3-520
|0 G:(DE-HGF)POF3-529H
|2 G:(DE-HGF)POF3-500
|v Addenda
|x 1
914 1 _ |y 2011
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |0 I:(DE-Juel1)IEK-8-20101013
|k IEK-8
|l Troposphäre
|g IEK
|x 0
920 1 _ |0 I:(DE-Juel1)PGI-7-20110106
|k PGI-7
|l Elektronische Materialien
|g PGI
|x 1
920 1 _ |0 I:(DE-82)080009_20140620
|k JARA-FIT
|l Jülich-Aachen Research Alliance - Fundamentals of Future Information Technology
|g JARA
|x 2
970 _ _ |a VDB:(DE-Juel1)131225
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)IEK-8-20101013
980 _ _ |a I:(DE-Juel1)PGI-7-20110106
980 _ _ |a I:(DE-82)080009_20140620
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)ICE-3-20101013
981 _ _ |a I:(DE-Juel1)PGI-7-20110106
981 _ _ |a I:(DE-Juel1)VDB881


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21